Literature DB >> 27708948

Churg-Strauss syndrome occurring during omalizumab treatment.

Muhammed Bekçibaşı1, Sezgin Barutçu2, Mustafa Kemal Çelen3, Saim Dayan3, Salih Hoşoğlu3.   

Abstract

Entities:  

Year:  2015        PMID： 27708948      PMCID： PMC5047257          DOI： 10.5152/eurjrheum.2015.0086

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


× No keyword cloud information.
  9 in total

Review 1.  Churg-Strauss syndrome.

Authors:  J G Lanham
Journal:  Br J Hosp Med       Date:  1992 May 6-19

2.  Omalizumab for asthma.

Authors:  David E Winchester; Ashok Jacob; Tom Murphy
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

3.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

4.  Omalizumab treatment associated with Churg-Strauss vasculitis.

Authors:  Elena Bargagli; Paola Rottoli
Journal:  Int Arch Allergy Immunol       Date:  2007-10-05       Impact factor: 2.749

5.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

6.  Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Authors:  M Humbert; R Beasley; J Ayres; R Slavin; J Hébert; J Bousquet; K-M Beeh; S Ramos; G W Canonica; S Hedgecock; H Fox; M Blogg; K Surrey
Journal:  Allergy       Date:  2005-03       Impact factor: 13.146

7.  Epidemiology of systemic vasculitis: changing incidence or definition?

Authors:  R A Watts; D M Carruthers; D G Scott
Journal:  Semin Arthritis Rheum       Date:  1995-08       Impact factor: 5.532

8.  Administration of anti-IgE to a Churg-Strauss syndrome patient.

Authors:  Pedro Giavina-Bianchi; Mara Giavina-Bianchi; Rosana Agondi; Jorge Kalil
Journal:  Int Arch Allergy Immunol       Date:  2007-05-29       Impact factor: 2.749

9.  Churg-strauss syndrome in patients treated with omalizumab.

Authors:  Michael E Wechsler; Dennis A Wong; Mary K Miller; Lisa Lawrence-Miyasaki
Journal:  Chest       Date:  2009-05-01       Impact factor: 9.410
  9 in total
  3 in total

Review 1.  Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.

Authors:  Loïc Raffray; Loïc Guillevin
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

Review 2.  Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.

Authors:  Erika P Navarro-Mendoza; Gabriel J Tobón
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

3.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.